KR101561709B1 - 올리고펩티드 티로시나제 억제제 및 그의 용도 - Google Patents

올리고펩티드 티로시나제 억제제 및 그의 용도 Download PDF

Info

Publication number
KR101561709B1
KR101561709B1 KR1020107001770A KR20107001770A KR101561709B1 KR 101561709 B1 KR101561709 B1 KR 101561709B1 KR 1020107001770 A KR1020107001770 A KR 1020107001770A KR 20107001770 A KR20107001770 A KR 20107001770A KR 101561709 B1 KR101561709 B1 KR 101561709B1
Authority
KR
South Korea
Prior art keywords
peptide
tyrosinase
formulation
peptides
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020107001770A
Other languages
English (en)
Korean (ko)
Other versions
KR20100109890A (ko
Inventor
바실 엠. 한타쉬
Original Assignee
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 filed Critical 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티
Publication of KR20100109890A publication Critical patent/KR20100109890A/ko
Application granted granted Critical
Publication of KR101561709B1 publication Critical patent/KR101561709B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020107001770A 2007-06-27 2008-06-25 올리고펩티드 티로시나제 억제제 및 그의 용도 Active KR101561709B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93739207P 2007-06-27 2007-06-27
US60/937,392 2007-06-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157017755A Division KR20150083931A (ko) 2007-06-27 2008-06-25 올리고펩티드 티로시나제 억제제 및 그의 용도

Publications (2)

Publication Number Publication Date
KR20100109890A KR20100109890A (ko) 2010-10-11
KR101561709B1 true KR101561709B1 (ko) 2015-10-22

Family

ID=40186021

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020157017755A Withdrawn KR20150083931A (ko) 2007-06-27 2008-06-25 올리고펩티드 티로시나제 억제제 및 그의 용도
KR1020107001770A Active KR101561709B1 (ko) 2007-06-27 2008-06-25 올리고펩티드 티로시나제 억제제 및 그의 용도

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020157017755A Withdrawn KR20150083931A (ko) 2007-06-27 2008-06-25 올리고펩티드 티로시나제 억제제 및 그의 용도

Country Status (7)

Country Link
US (2) US7902329B2 (enExample)
EP (1) EP2173370B1 (enExample)
JP (2) JP5587772B2 (enExample)
KR (2) KR20150083931A (enExample)
CN (2) CN104083752B (enExample)
CA (2) CA2728122C (enExample)
WO (1) WO2009003034A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641591B1 (en) 1999-08-26 2003-11-04 John H. Shadduck Instruments and techniques for controlled removal of epidermal layers
US8048089B2 (en) 2005-12-30 2011-11-01 Edge Systems Corporation Apparatus and methods for treating the skin
WO2014151104A1 (en) 2013-03-15 2014-09-25 Edge Systems Llc Devices, systems and methods for treating the skin
US10172644B2 (en) 2006-03-29 2019-01-08 Edge Systems Llc Devices, systems and methods for treating the skin
US9566088B2 (en) 2006-03-29 2017-02-14 Edge Systems Llc Devices, systems and methods for treating the skin
KR101836310B1 (ko) 2008-01-04 2018-03-08 엣지 시스템즈 엘엘씨 피부 처리 장치 및 방법
US9056193B2 (en) 2008-01-29 2015-06-16 Edge Systems Llc Apparatus and method for treating the skin
EP2451367B1 (en) 2009-07-08 2020-01-22 Edge Systems Corporation Devices for treating the skin using time-release substances
WO2011116072A1 (en) 2010-03-16 2011-09-22 Escape Therapeutics, Inc. Hybrid hydrogel scaffold compositions and methods of use
EP2382963A1 (en) 2010-04-29 2011-11-02 Cognis IP Management GmbH Cosmetic composition containing oligopeptides
CN102492018A (zh) * 2010-07-27 2012-06-13 萧乃文 酪氨酸酶多肽抑制剂
US10238812B2 (en) 2013-03-15 2019-03-26 Edge Systems Llc Skin treatment systems and methods using needles
US9567368B2 (en) * 2013-11-29 2017-02-14 Escape Therapeutics, Inc. Peptide tyrosinase activators
EP2990027A1 (en) 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
EP4324414A3 (en) 2014-12-23 2024-05-01 HydraFacial LLC Devices and methods for treating the skin using a rollerball or a wicking member
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
US11241357B2 (en) 2015-07-08 2022-02-08 Edge Systems Llc Devices, systems and methods for promoting hair growth
CN105177092A (zh) * 2015-09-23 2015-12-23 华侨大学 一种具有美白功效的活性多肽的生物发酵制备方法
US20180296456A1 (en) * 2017-03-30 2018-10-18 Escape Therapeutics, Inc. Decapeptide-12 Modulation of Sirtuin Gene Expression in Epidermal Keratinocyte Progenitors
CN107253977B (zh) * 2017-07-03 2020-04-28 大连理工大学 抑制黑色素生成抗氧化的小肽、制备方法及其应用
CN108837142A (zh) * 2018-07-20 2018-11-20 厦门艾赛生物科技有限公司 一种可修复皮肤的干细胞外泌体及其制备方法和应用
JP7241483B2 (ja) * 2018-07-23 2023-03-17 株式会社ノエビア 皮膚用組成物
CN108948151B (zh) * 2018-08-06 2019-06-21 山西锦波生物医药股份有限公司 肽及其制备方法和用途
MX2020014330A (es) * 2018-12-26 2021-03-09 Caregen Co Ltd Composicion para relajacion muscular.
JP7689073B2 (ja) * 2019-01-19 2025-06-05 エスケープ・セラピューティクス・インコーポレイテッド ヒト新生児ケラチノサイト前駆細胞において免疫抑制活性を有するチロシン阻害剤
CA3131382A1 (en) * 2019-02-25 2020-09-03 Topix Pharmaceuticals, Inc. Methods, compositions, sheets for therapeutic skin treatments
US11291474B2 (en) 2020-01-06 2022-04-05 Ed F. Nicolas Skin treatment tool applicator tip
US20230391825A1 (en) * 2020-10-20 2023-12-07 Escape Therapeutics, Inc. Enhanced skin permeation of a novel peptide via structural modification, chemical enhancement, and microneedles
KR102506020B1 (ko) * 2020-11-27 2023-03-06 웰펩 주식회사 항산화 활성 및 티로시나제 저해활성을 갖는 펩타이드 및 이를 포함하는 조성물
USD1065551S1 (en) 2021-09-10 2025-03-04 Hydrafacial Llc Skin treatment device
USD1016615S1 (en) 2021-09-10 2024-03-05 Hydrafacial Llc Container for a skin treatment device
USD1042807S1 (en) 2021-10-11 2024-09-17 Hydrafacial Llc Skin treatment tip
USD1084369S1 (en) 2023-02-10 2025-07-15 Hydrafacial Llc Skin treatment tip

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100865061B1 (ko) 2005-09-21 2008-10-23 로레알 티로시나제 발현을 억제하는 이중 가닥 ｒｎａ올리고뉴클레오티드

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3978427A (en) 1973-06-15 1976-08-31 American Optical Corporation Erbium laser device having non-masking laser rod holders
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
IT1164225B (it) 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
EP0389950A1 (en) 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5773291A (en) 1989-04-26 1998-06-30 Sloan-Kettering Institute For Cancer Research Non-melanotytic mammalian cell constitutively expressing biologically active human tyrosinase and use thereof
JPH06505701A (ja) * 1990-09-10 1994-06-30 スクール・オブ・フアーマシー・ユニバーシテイ・オブ・ロンドン リポソーム
US5543389A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
AU1194092A (en) 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
US5455228A (en) 1993-07-02 1995-10-03 The Research Foundation Of State University Of New York Peptidase resistant thrombin receptor peptide ligand
US5589460A (en) 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6602856B1 (en) 1995-01-17 2003-08-05 J. Mark Quillan Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
ES2175083T3 (es) 1995-03-14 2002-11-16 Praecis Pharm Inc Moduladores de la agregacion de amiloides.
DE69738930D1 (de) 1996-03-28 2008-10-02 Univ Boston Methoden zur modulation der melaninsynthese
US6143723A (en) * 1996-05-20 2000-11-07 Ramaiah; Abburi Pigmentory agent
US6165982A (en) 1996-11-08 2000-12-26 Seiren Co., Ltd. Use of sericin as antioxidants and tyrosinase inhibitors
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6368877B1 (en) 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US6287590B1 (en) 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US7083781B2 (en) 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US6283978B1 (en) * 2000-06-09 2001-09-04 Peter J. Cheski Method and apparatus for microdermabrasion
CA2412011A1 (en) 2000-06-16 2001-12-27 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
JP2004535792A (ja) 2001-04-27 2004-12-02 ザ ジェネラル ホスピタル コーポレーション チロシナーゼアッセイ法
US7658742B2 (en) * 2001-11-21 2010-02-09 Envy Medical, Inc. Skin treatment system and method of use
US6695853B2 (en) 2001-11-21 2004-02-24 Emed, Inc. Microdermabrasion system and method of use
US6649150B2 (en) 2002-04-11 2003-11-18 Em Industries Skin-lightening
US7025957B2 (en) 2002-09-06 2006-04-11 Desert Whale Jojoba Company Composition and method to whiten skin
US7125572B2 (en) 2004-05-14 2006-10-24 Kaoder Industry Company, Ltd. Tyrosinase inhibitor extract
WO2007001868A1 (en) 2005-06-28 2007-01-04 Genentech, Inc. Egfr and kras mutations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100865061B1 (ko) 2005-09-21 2008-10-23 로레알 티로시나제 발현을 억제하는 이중 가닥 ｒｎａ올리고뉴클레오티드

Also Published As

Publication number Publication date
JP2011504165A (ja) 2011-02-03
CN101795702A (zh) 2010-08-04
CN101795702B (zh) 2014-08-06
KR20100109890A (ko) 2010-10-11
CA2970108A1 (en) 2008-12-31
EP2173370A1 (en) 2010-04-14
JP2014159442A (ja) 2014-09-04
KR20150083931A (ko) 2015-07-20
CA2728122A1 (en) 2008-12-31
CA2728122C (en) 2017-07-25
US20090099091A1 (en) 2009-04-16
WO2009003034A1 (en) 2008-12-31
CN104083752A (zh) 2014-10-08
EP2173370B1 (en) 2015-10-21
US8193154B2 (en) 2012-06-05
US20110091530A1 (en) 2011-04-21
CA2970108C (en) 2020-04-07
WO2009003034A8 (en) 2010-09-16
CN104083752B (zh) 2018-04-10
EP2173370A4 (en) 2012-03-07
JP5587772B2 (ja) 2014-09-10
US7902329B2 (en) 2011-03-08

Similar Documents

Publication Publication Date Title
KR101561709B1 (ko) 올리고펩티드 티로시나제 억제제 및 그의 용도
KR101507188B1 (ko) 펩티드 티로시나제 억제제 및 그의 용도
CN103096980B (zh) 皮肤抗衰老治疗
US9567368B2 (en) Peptide tyrosinase activators
ES2578636T3 (es) Péptidos novedosos antienvejecimiento y composición cosmética y/o farmacéutica que los contiene
KR20200024235A (ko) 피부, 모발, 손톱 및/또는 점막의 치료 및/또는 관리에 유용한 화합물
US9320698B2 (en) Peptide tyrosinase inhibitors and uses thereof
US20060293227A1 (en) Cosmetic compositions and methods using transforming growth factor-beta mimics
US20070154437A1 (en) Peptide-tagged proteins and methods of making and using thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100126

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130625

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141006

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150303

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141006

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20150602

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20150303

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20150807

Appeal identifier: 2015101003169

Request date: 20150602

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150702

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20150602

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20150602

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20150206

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20130625

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20150807

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20150703

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20151013

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20151013

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20181001

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20190917

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20201005

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20211005

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20220929

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20231004

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20240927

Start annual number: 10

End annual number: 10